Our leadership

With a seasoned leadership team with world-class expertise spanning research, clinical development, regulatory, manufacturing and commercial experience in hematologic malignancies, Geron is prepared to deliver on our mission to change lives by changing the course of blood cancer.

Management

John A. Scarlett, M.D.

Chairman of the Board, President and Chief Executive Officer
Melissa A. Kelly Behrs

Executive Vice President, Business Operations and Chief Alliance Officer
Joseph Eid, M.D.

Executive Vice President, Research and Development
Faye Feller, M.D.

Executive Vice President, Chief Medical Officer
Andrew J. Grethlein, Ph.D.

Executive Vice President, Chief Operating Officer
Edward Koval

Executive Vice President and Chief Business Officer
Shannon T. Odam

Senior Vice President, Chief People Officer
Michelle Robertson

Executive Vice President, Chief Financial Officer and Treasurer
Scott A. Samuels, Esq. 

Executive Vice President, Chief Legal Officer and Secretary

Jim Ziegler

Executive Vice President, Chief Commercial Officer

Board of Directors

John A. Scarlett, M.D.

Chairman of the Board, President and Chief Executive Officer
Gaurav Aggarwal, M.D.

Compensation Committee, Strategic Committee (Chair)
Dawn C. Bir

Nominating and Corporate Governance Committee (Chair), Compensation Committee
V. Bryan Lawlis, Ph.D.

Audit Committee, Nominating and Corporate Governance Committee
John F. McDonald

Audit Committee, Strategic Committee
Susan M. Molineaux, Ph.D.

Compensation Committee (Chair), Nominating and Corporate Governance Committee
Elizabeth G. O’Farrell

Lead Director, Audit Committee (Chair), Strategic Committee
Robert J. Spiegel, M.D., FACP

Compensation Committee, Nominating and Corporate Governance Committee
Culture

We see things in ways others do not